for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Davita Inc

DVA

Latest Trade

84.83USD

Change

-0.30(-0.35%)

Volume

856,144

Today's Range

82.58

 - 

84.86

52 Week Range

54.09

 - 

92.67

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
85.12
Open
84.54
Volume
856,144
3M AVG Volume
21.72
Today's High
84.86
Today's Low
82.58
52 Week High
92.67
52 Week Low
54.09
Shares Out (MIL)
121.98
Market Cap (MIL)
11,005.52
Forward P/E
12.98
Dividend (Yield %)
--

Next Event

Q3 2020 DaVita Inc Earnings Release

Latest Developments

More

Ted Weschler Reports Open Market Sale Of 2.2 Mln Shares Pf Davita Inc Common Stock At $88/Share On Sept 17 - SEC Filing

Berkshire Hathaway Reports Open Market Sale Of 2.0 Mln Shares Of Davita Common Stock At $88/Share On Sept 17 - SEC Filing

Davita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Davita Inc

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.

Industry

Healthcare Facilities

Contact Info

2000 16th St

DENVER, CO

80202-5158

United States

+1.310.5362668

https://www.davita.com/

Executive Leadership

Pamela M. Arway

Independent Chairman of the Board

Javier J. Rodriguez

Chief Executive Officer, Director

Joel Ackerman

Chief Financial Officer, Treasurer

John D. Winstel

Chief Accounting Officer

James O. Hearty

Chief Compliance Officer

Key Stats

2.67 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

15.6K

2018

11.4K

2019

11.4K

2020(E)

11.6K
EPS (USD)

2017

3.320

2018

3.570

2019

5.400

2020(E)

6.851
Price To Earnings (TTM)
13.89
Price To Sales (TTM)
0.96
Price To Book (MRQ)
4.95
Price To Cash Flow (TTM)
6.60
Total Debt To Equity (MRQ)
455.04
LT Debt To Equity (MRQ)
366.53
Return on Investment (TTM)
7.88
Return on Equity (TTM)
5.31

Latest News

Latest News

BRIEF-Davita Announces Pricing Of $1.75 Bln Senior Notes Offering

* DAVITA INC. ANNOUNCES PRICING OF $1.75 BILLION SENIOR NOTES OFFERING

BRIEF-Davita Inc. Announces Offering Of $1.75 Billion Senior Notes

* DAVITA INC. ANNOUNCES OFFERING OF $1.75 BILLION SENIOR NOTES

BRIEF-Davita Reports Q1 Results

* Q1 ADJUSTED EARNINGS PER SHARE $1.83 FROM CONTINUING OPERATIONS

BRIEF-DaVita Launches Venture Group To Accelerate Advancements In Kidney Care

* DAVITA LAUNCHES VENTURE GROUP TO ACCELERATE ADVANCEMENTS IN KIDNEY CARE Source text for Eikon: Further company coverage:

BRIEF-Davita Inc. Provides Commentary On COVID-19 Pandemic

* DAVITA INC - SCREENING EVERY PERSON WHO ENTERS A DAVITA CENTER FOR SYMPTOMS AND EXPOSURE TO COVID-19

BRIEF-Davita Kidney Care Says Plans To Hire At Least 15,000 New Employees Throughout 2020

* DAVITA KIDNEY CARE SAYS PLANS TO HIRE AT LEAST 15,000 NEW EMPLOYEES THROUGHOUT 2020 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Fresenius Medical Care working with dialysis providers in U.S. to tackle coronavirus

Fresenius Medical Care (FMC) on Wednesday said it was working with other dialysis providers to provide care in isolation for people with kidney problems in the United States who are or may be infected with coronavirus.

BRIEF-Davita Kidney Care To Give U.S. Employees An Extra $100 Each Week

* DAVITA KIDNEY CARE - ANNOUNCED IT IS GIVING U.S. EMPLOYEES, KNOWN AS TEAMMATES, AN EXTRA $100 EACH WEEK Source text for Eikon: Further company coverage:

DaVita, Fresenius used kidney disease charity to pay kickbacks - lawsuit

Dialysis providers DaVita Inc and Fresenius Medical Care violated an anti-kickback law by contributing to a charity that helps kidney disease patients afford treatment that then steered business to them, a newly unsealed whistleblower lawsuit alleges.

UnitedHealth gets FTC approval for DaVita unit purchase

UnitedHealth Group Inc won anti-trust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday.

U.S. FTC approves UnitedHealth's proposed purchase of DaVita unit

UnitedHealth Group Inc won antitrust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday. (Reporting by Diane Bartz Editing by Leslie Adler)

DaVita settles with dialysis patients' families over deaths for $25.5 mln

DaVita Inc will pay $25.5 million to the families of three patients who won a $383.5 million jury verdict and who claimed their relatives suffered cardiac arrests and died soon after receiving dialysis treatments at the company's clinics.

DaVita unit to pay $270 million to resolve Medicare payments probe

A medical care unit of DaVita Inc <DVA.N> has agreed to pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.

DaVita resolves U.S. probe into Medicare payments for $270 mln

A medical care unit of DaVita Inc will pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.

U.S. jury orders DaVita to pay $383.5 million in wrongful death lawsuits

A federal jury in Colorado has awarded $383.5 million to the families of three patients who said they suffered cardiac arrests and died soon after receiving dialysis treatments at clinics run by DaVita Inc.

BRIEF-Berkshire Hathaway Inc Reports 22.1 Percent Stake In Davita Inc As Of May 3, 2018

* BERKSHIRE HATHAWAY INC REPORTS 22.1 PERCENT STAKE IN DAVITA INC AS OF MAY 3, 2018 - SEC FILING

BRIEF-DaVita Reports Q1 Earnings Per Share $1.05 From Continuing Operations

* Q1 EARNINGS PER SHARE VIEW $0.93 -- THOMSON REUTERS I/B/E/S

BRIEF-DaVita Says CEO Kent Thiry's Total 2017 Compensation Was $15.3 Mln

* DAVITA INC SAYS CEO KENT THIRY'S TOTAL 2017 COMPENSATION WAS $15.3 MILLION VERSUS $12.3 MILLION IN 2016

BRIEF-Davita Inc Reports Q4 Earnings Per Share $0.85 From Continuing Operations

* Q4 ADJUSTED EARNINGS PER SHARE $0.92 FROM CONTINUING OPERATIONS

BRIEF-Davita Kidney Care Issues Statement About Davita Rx Settlement

* DAVITA KIDNEY CARE ISSUES STATEMENT ABOUT DAVITA RX SETTLEMENT

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up